Raymond Huggenberger - 15 Sep 2021 Form 4 Insider Report for Inogen Inc (INGN)

Role
Director
Signature
/s/ Alison Bauerlein, as Attorney-in-Fact
Issuer symbol
INGN
Transactions as of
15 Sep 2021
Net transactions value
-$41,840
Form type
4
Filing time
17 Sep 2021, 16:53:12 UTC
Previous filing
18 Aug 2021
Next filing
11 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INGN Common Stock Options Exercise $154,160 +4,000 +23% $38.54* 21,583 15 Sep 2021 Direct
transaction INGN Common Stock Sale $196,000 -4,000 -19% $49.00* 17,583 15 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INGN Stock Option (Right to Buy) Options Exercise $0 -4,000 -25% $0.000000 11,806 15 Sep 2021 Common Stock 4,000 $38.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
F2 Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option was May 1, 2015.